CoE-applicant from the Institute for cancer research to final round
In December 2006, between five and ten new centres of excellence will be selected by the Research Council. 26 of the total of 98 research groups that have applied for CoE-status from 2007 have reached the final selection round. Among the finalists is the application from the "Centre for Cancer Biomedicine" at Norwegian Radium Hospital, with Harald A. Stenmark as proposed CoE director. At present, there are 13 established Norwegian Centres of Excellence in all fields of science.
The Centres of Excellence (CoE) scheme, which is initiated by the Research Council of Norway, has the intention to bring more Norwegian researchers and research groups up to a high international standard. The centres are devoted to long-term, basic research.
Grindedal EM, Zucknick M, Stormorken A, Rønne E, Tandstad NM, Isaacs WB, Axcrona K, Mæhle L(2024) Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome Prostate(in press) DOI 10.1002/pros.24711, PubMed 38629217
Meriranta L, Sorri S, Huse K, Liu X, Spasevska I, Zafar S, Chowdhury I, Dufva O, Sahlberg E, Tandaric L, Karjalainen-Lindsberg ML, Hyytiainen M, Varjosalo M, Myklebust JH, Leppa S(2024) Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma Blood Cancer Discov(in press) DOI 10.1158/2643-3230.BCD-23-0182, PubMed 38630892
Suske T, Sorger H, Manhart G, Ruge F, Prutsch N, Zimmerman MW, Eder T, Abdallah DI, Maurer B, Wagner C, Schönefeldt S, Spirk K, Pichler A, Pemovska T, Schweicker C, Pölöske D, Hubanic E, Jungherz D, Müller TA, Aung MMK, Orlova A, Pham HTT, Zimmel K, Krausgruber T, Bock Cet al.(2024) Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia J Clin Invest, 134(8) DOI 10.1172/JCI168536, PubMed 38618957